High performance liquid chromatographic determination of Bifidobacterium bifidum growth factors in human milk. 1983

S H Ashoor, and W C Monte

An isocratic high performance liquid chromatography (HPLC) method has been developed for the determination of Bifidobacterium bifidum growth factors in human milk. The method involves the gradual addition of 3 volumes of ethanol to the milk sample, filtration, and analysis of the growth factors in the filtrate by HPLC. The HPLC system consisted of a carbohydrate analysis column, a water-acetonitrile (70 + 30) solvent system, a flow rate of 1.0 mL/min, and a refractive index detector. The method is simpler and requires less time than the present microbiological method. Moreover, it revealed for the first time the presence of 2 separable growth factors in all human milk samples tested. The HPLC method developed is sensitive and can be used to monitor the type and the amount of growth factors in mothers' milk during lactation.

UI MeSH Term Description Entries
D008895 Milk, Human Milk that is produced by HUMAN MAMMARY GLANDS. Breast Milk,Human Milk,Milk, Breast
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005260 Female Females
D006133 Growth Substances Signal molecules that are involved in the control of cell growth and differentiation. Mitogens, Endogenous,Endogenous Mitogens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000191 Actinomycetaceae A family of bacteria including numerous parasitic and pathogenic forms.
D001681 Biological Assay A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. Bioassay,Assay, Biological,Assays, Biological,Biologic Assay,Biologic Assays,Assay, Biologic,Assays, Biologic,Bioassays,Biological Assays

Related Publications

S H Ashoor, and W C Monte
July 1981, Journal - Association of Official Analytical Chemists,
S H Ashoor, and W C Monte
September 1980, Journal - Association of Official Analytical Chemists,
S H Ashoor, and W C Monte
September 1979, Journal of pharmaceutical sciences,
S H Ashoor, and W C Monte
January 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
S H Ashoor, and W C Monte
August 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
S H Ashoor, and W C Monte
September 1981, Journal - Association of Official Analytical Chemists,
S H Ashoor, and W C Monte
April 2004, Journal of chromatography. A,
S H Ashoor, and W C Monte
July 1989, Biomedical chromatography : BMC,
S H Ashoor, and W C Monte
June 1986, Journal of chromatography,
Copied contents to your clipboard!